help button home button Endocrine Society Molecular Endocrinology ENDO 08 Sessions Library
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hedvat, C. V.
Right arrow Articles by Irving, S. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hedvat, C. V.
Right arrow Articles by Irving, S. G.

Molecular Endocrinology, Vol 9, 1692-1700, Copyright © 1995 by Endocrine Society


ARTICLES

The isolation and characterization of MINOR, a novel mitogen-inducible nuclear orphan receptor

CV Hedvat and SG Irving
Department of Pathology, Georgetown University School of Medicine, Washington, DC 20007, USA.

The nuclear (steroid/thyroid/retinoid) receptor superfamily is a set of evolutionarily related ligand-inducible regulators of transcription. One subgroup within this family has been termed the orphan receptors because the potential ligands required for their activity have not been identified. We have cloned a novel orphan receptor, MINOR, which is mitogen inducible in a variety of cell types. Unlike NGFI-B/Nur77, another mitogen-inducible orphan receptor, MINOR gene expression is inhibited in Jurkat cells by the immunosuppressant cyclosporin A, suggesting that it is regulated by distinct second messenger pathways. The conservation of the DNA-binding domain between MINOR and other orphan receptors is reflected in the fact that they are able to bind to the same sequence, AAAG-GTCA [termed the NBRE (NGFI-B response element)]. The marked divergence in other domains, particularly the N- terminal putative transactivation domain, may result in qualitative or quantitative differences in other functions among these proteins. One of these differences may be the apparent squelching of peak levels of MINOR-mediated transcription by supraoptimal levels of MINOR expression, an effect not obtained with NGFI-B/Nur77. When MINOR i coexpressed with submaximal levels of NGFI-B/Nur77, synergistic or additive levels of reporter gene expression are obtained. However, at maximal levels of NGFI-B/Nur77 expression, MINOR antagonizes the level of reporter gene expression in a dose-dependent fashion. These cooperative/competitive interactions, together with the nonidentical expression patterns of MINOR and NGFI-B/Nur77, suggest complexity in the regulation of genes responsive to orphan receptors which bind to the NBRE.


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
Y. Fu, L. Luo, N. Luo, X. Zhu, and W. T. Garvey
NR4A Orphan Nuclear Receptors Modulate Insulin Action and the Glucose Transport System: POTENTIAL ROLE IN INSULIN RESISTANCE
J. Biol. Chem., October 26, 2007; 282(43): 31525 - 31533.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
G. Benoit, A. Cooney, V. Giguere, H. Ingraham, M. Lazar, G. Muscat, T. Perlmann, J.-P. Renaud, J. Schwabe, F. Sladek, et al.
International Union of Pharmacology. LXVI. Orphan Nuclear Receptors
Pharmacol. Rev., December 1, 2006; 58(4): 798 - 836.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
H. Zeng, L. Qin, D. Zhao, X. Tan, E. J. Manseau, M. Van Hoang, D. R. Senger, L. F. Brown, J. A. Nagy, and H. F. Dvorak
Orphan nuclear receptor TR3/Nur77 regulates VEGF-A-induced angiogenesis through its transcriptional activity
J. Exp. Med., March 20, 2006; 203(3): 719 - 729.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
M. G. Yeo, Y.-G. Yoo, H.-S. Choi, Y. K. Pak, and M.-O. Lee
Negative Cross-Talk between Nur77 and Small Heterodimer Partner and Its Role in Apoptotic Cell Death of Hepatoma Cells
Mol. Endocrinol., April 1, 2005; 19(4): 950 - 963.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
X. Cao, W. Liu, F. Lin, H. Li, S. K. Kolluri, B. Lin, Y.-h. Han, M. I. Dawson, and X.-k. Zhang
Retinoid X Receptor Regulates Nur77/Thyroid Hormone Receptor 3-Dependent Apoptosis by Modulating Its Nuclear Export and Mitochondrial Targeting
Mol. Cell. Biol., November 15, 2004; 24(22): 9705 - 9725.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
H.-J. Shin, B.-H. Lee, M. G. Yeo, S.-H. Oh, J.-D. Park, K.-K. Park, J.-H. Chung, C.-K. Moon, and M.-O. Lee
Induction of orphan nuclear receptor Nur77 gene expression and its role in cadmium-induced apoptosis in lung
Carcinogenesis, August 1, 2004; 25(8): 1467 - 1475.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
H. Sjogren, J. M. Meis-Kindblom, C. Orndal, P. Bergh, K. Ptaszynski, P. Aman, L.-G. Kindblom, and G. Stenman
Studies on the Molecular Pathogenesis of Extraskeletal Myxoid Chondrosarcoma--Cytogenetic, Molecular Genetic, and cDNA Microarray Analyses
Am. J. Pathol., March 1, 2003; 162(3): 781 - 792.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
C. Laflamme, C. Filion, J. A. Bridge, M. Ladanyi, M. B. Goldring, and Y. Labelle
The Homeotic Protein Six3 Is a Coactivator of the Nuclear Receptor NOR-1 and a Corepressor of the Fusion Protein EWS/NOR-1 in Human Extraskeletal Myxoid Chondrosarcomas
Cancer Res., January 15, 2003; 63(2): 449 - 454.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
J. Martinez-Gonzalez, J. Rius, A. Castello, C. Cases-Langhoff, and L. Badimon
Neuron-Derived Orphan Receptor-1 (NOR-1) Modulates Vascular Smooth Muscle Cell Proliferation
Circ. Res., January 10, 2003; 92(1): 96 - 103.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
T. Ponnio, Q. Burton, F. A. Pereira, D. K. Wu, and O. M. Conneely
The Nuclear Receptor Nor-1 Is Essential for Proliferation of the Semicircular Canals of the Mouse Inner Ear
Mol. Cell. Biol., February 1, 2002; 22(3): 935 - 945.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
N. Ohkura, H. Yaguchi, T. Tsukada, and K. Yamaguchi
The EWS/NOR1 Fusion Gene Product Gains a Novel Activity Affecting Pre-mRNA Splicing
J. Biol. Chem., January 4, 2002; 277(1): 535 - 543.
[Abstract] [Full Text]


Home page
Endocr. Rev.Home page
V. Giguère
Orphan Nuclear Receptors: From Gene to Function
Endocr. Rev., October 1, 1999; 20(5): 689 - 725.
[Abstract] [Full Text]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
Y. Ueda, S. Bandoh, J. Fujita, M. Sato, Y. Yamaji, and J. Takahara
Expression of Nerve Growth Factor-Induced Clone B Subfamily and Pro-opiomelanocortin Gene in Lung Cancer Cell Lines
Am. J. Respir. Cell Mol. Biol., June 1, 1999; 20(6): 1319 - 1325.
[Abstract] [Full Text]


Home page
Mol. Endocrinol.Home page
E. P. Murphy and O. M. Conneely
Neuroendocrine Regulation of the Hypothalamic Pituitary Adrenal Axis by the nurr1/nur77 Subfamily of Nuclear Receptors
Mol. Endocrinol., January 1, 1997; 11(1): 39 - 47.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
C. J. M. de Vries, T. A. E. van Achterberg, A. J. G. Horrevoets, J. W. ten Cate, and H. Pannekoek
Differential Display Identification of 40 Genes with Altered Expression in Activated Human Smooth Muscle Cells. LOCAL EXPRESSION IN ATHEROSCLEROTIC LESIONS OF smags, SMOOTH MUSCLE ACTIVATION-SPECIFIC GENES
J. Biol. Chem., July 28, 2000; 275(31): 23939 - 23947.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1995 by The Endocrine Society